High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway

Nature Communications

Volumn 4, Issue , 2013, Pages

  Volpi, Claudia ^a   Fallarino, Francesca ^a   Pallotta, Maria T ^a   Bianchi, Roberta ^a   Vacca, Carmine ^a   Belladonna, Maria L ^a   Orabona, Ciriana ^a   De Luca, Antonella ^a   Boon, Louis ^b   Romani, Luigina ^a   Grohmann, Ursula ^a   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b BIOCEROS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 23; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN P19; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

CATABOLISM; CYTOLOGY; IMMUNE RESPONSE; IMMUNE SYSTEM; RODENT; SIGNAL;

ALLERGY; ARTICLE; CATABOLISM; CD8+ T LYMPHOCYTE; DRUG MEGADOSE; ENZYME ACTIVATION; IMMUNOSTIMULATION; IN VITRO SELECTION; IN VIVO STUDY; INFLAMMATION; PLASMACYTOID DENDRITIC CELL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, CD; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; INTERLEUKIN-23; MEMBRANE GLYCOPROTEINS; MICE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PNEUMONIA; SIGNAL TRANSDUCTION; SKIN TESTS; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84878707549     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2874     Document Type: Article

References (48)

1. Kortylewski, M. et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol 27, 925-932 (2009)
2. Klinman, D.M., Currie, D., Gursel, I. & Verthelyi, D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199, 201-216 (2004) (Pubitemid 38736773)
3. Mutwiri, G., van Drunen Littel-van den Hurk, S. & Babiuk, L.A. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv. Drug Deliv. Rev. 61, 226-232 (2009)
4. Hayashi, T. et al. Inhibition of experimental asthma by indoleamine 2,3- dioxygenase. J. Clin. Invest. 114, 270-279 (2004) (Pubitemid 39071632)
5. Christensen, S.R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417-428 (2006) (Pubitemid 44354217)
6. Mellor, A.L. et al. Cutting Edge: CpG oligonucleotides induce splenic CD19 dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol 175, 5601-5605 (2005) (Pubitemid 41508038)
7. Fallarino, F. & Puccetti, P. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur. J. Immunol 36, 8-11 (2006) (Pubitemid 43116386)
8. Wingender, G. et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol 36, 12-20 (2006) (Pubitemid 43116387)
9. Boor, P.P. et al. Human plasmacytoid dendritic cells induce CD8 LAG-3 Foxp3 CTLA-4 regulatory T cells that suppress allo-reactive memory T cells. Eur. J. Immunol 41, 1663-1674 (2011)
10. Volpi, C. et al. A GpC-rich oligonucleotide acts on plasmacytoid dendritic cells to promote immune suppression. J. Immunol 189, 2283-2289 (2012)
11. Puccetti, P. et al. Use of a skin test assay to determine tumor-specific CD8 T cell reactivity. Eur. J. Immunol 24, 1446-1452 (1994) (Pubitemid 24169532)
12. Pallotta, M.T. et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol 12, 870-878 (2011)
13. Fallarino, F. et al. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J. Immunol 183, 6303-6312 (2009)
14. Grohmann, U. et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J. Immunol 171, 2581-2587 (2003) (Pubitemid 37025569)
15. Belladonna, M.L. et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol 168, 5448-5454 (2002) (Pubitemid 34556122)
16. Grohmann, U. et al. IL-6 inhibits the tolerogenic function of CD8a dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol 167, 708-714 (2001) (Pubitemid 32660823)
17. Belladonna, M.L. et al. Cutting edge: autocrine TGF-b sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol 181, 5194-5198 (2008)
18. Orabona, C. et al. Toward the identification of a tolerogenic signature in IDOcompetent dendritic cells. Blood 107, 2846-2854 (2006)
19. Puccetti, P. & Grohmann, U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kB activation. Nat. Rev. Immunol 7, 817-823 (2007) (Pubitemid 47480306)
20. Orabona, C. et al. SOCS3 drives proteasomal degradation of indoleamine 2,3- dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc. Natl Acad. Sci. USA 105, 20828-20833 (2008)
21. Belladonna, M.L., Orabona, C., Grohmann, U. & Puccetti, P. TGF-b and kynurenines as the key to infectious tolerance. Trends Mol. Med. 15, 41-49 (2009)
22. Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor z-chain and induce a regulatory phenotype in naive T cells. J. Immunol 176, 6752-6761 (2006) (Pubitemid 43787857)
23. Habelhah, H. Emerging complexity of protein ubiquitination in the NF-kB pathway. Genes Cancer 1, 735-747 (2010)
24. Zarnegar, B.J. et al. Noncanonical NF-kB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol 9, 1371-1378 (2008)
25. Inoue, J., Gohda, J. & Akiyama, T. Characteristics and biological functions of TRAF6. Adv. Exp. Med. Biol. 597, 72-79 (2007)
26. Grohmann, U. et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med 13, 579-586 (2007) (Pubitemid 46828479)
27. Tas, S.W. et al. Noncanonical NF-kB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110, 1540-1549 (2007) (Pubitemid 47443970)
28. Kaisho, T. & Tanaka, T. Turning NF-kB and IRFs on and off in DC. Trends Immunol 29, 329-336 (2008)
29. O'Neill, L.A. & Bowie, A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353-364 (2007) (Pubitemid 46674493)
30. Tatematsu, M. et al. A molecular mechanism for Toll-IL-1 receptor domaincontaining adaptor molecule-1-mediated IRF-3 activation. J. Biol. Chem 285, 20128-20136 (2010)
31. Johnson, J. et al. A conventional protein kinase C inhibitor targeting IRF-3-dependent genes differentially regulates IL-12 family members. Mol. immunol 48, 1484-1493 (2011)
32. Bhattacharyya, S., Zhao, Y., Kay, T.W. & Muglia, L.J. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc. Natl Acad. Sci. USA 108, 9554-9559 (2011)
33. Moseman, E.A. et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4CD25 regulatory T cells. J. Immunol 173, 4433-4442 (2004) (Pubitemid 39280673)
34. Romani, L. et al. Thymosin a1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108, 2265-2274 (2006) (Pubitemid 44497509)
35. Romani, L. et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451, 211-215 (2008)
36. Romani, L. Immunity to fungal infections. Nat. Rev. Immunol. 11, 275-288 (2011)
37. Ramirez-Ortiz, Z.G. et al. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 9, 415-424 (2011)
38. Bonifazi, P. et al. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol 3, 193-205 (2010)
39. Romani, L., Zelante, T., De Luca, A., Fallarino, F. & Puccetti, P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. immunol 180, 5157-5162 (2008)
40. Colonna, M., Trinchieri, G. & Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226 (2004) (Pubitemid 41057736)
41. Heikenwalder, M. et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med 10, 187-192 (2004) (Pubitemid 38524890)
42. Verthelyi, D. & Zeuner, R.A. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol 24, 519-522 (2003) (Pubitemid 37205200)
43. Biswas, S.K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009)
44. Covert, M.W., Leung, T.H., Gaston, J.E. & Baltimore, D. Achieving stability of lipopolysaccharide-induced NF-kB activation. Science 309, 1854-1857 (2005) (Pubitemid 41325095)
45. Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin, M. IKKa limits macrophage NF-kB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005) (Pubitemid 40663493)
46. Foligne, B. et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2, e313-e324 (2007)
47. Fallarino, F. et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol 173, 3748-3754 (2004) (Pubitemid 39280736)
48. Fallarino, F. et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol 17, 1429-1438 (2005). (Pubitemid 41631319)